Indian Roxithromycin Exporters: Complete Supplier Ranking with Market Share — 78 Manufacturers (2026) — TransData Nexus

Q: Who is the largest roxithromycin supplier from India?

BRAWN LABORATORIES LIMITED is the largest roxithromycin exporter from India with a 30.3% market share and export value of $1.3M.

Q: How many roxithromycin suppliers are there in India?

There are 78 active roxithromycin exporters in India, collectively shipping $4.2M worth of roxithromycin across 427 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top roxithromycin suppliers from India?

The top 5 roxithromycin suppliers from India — BRAWN LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED, MARKSANS PHARMA LIMITED, TORRENT PHARMACEUTICALS LTD, GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED — together control 70.6% of total roxithromycin export value from India.

Suresh Sormare

Roxithromycin

India Pharmaceutical Trade Intelligence

$4.2M78 Suppliers30 CountriesHS 30049099

ExportsIndia → VIETNAM33.9%India → CAMBODIA18.3%

ImportsGERMANY → India$752

#1 Supplier: BRAWN LABORATORIES

Roxithromycin Suppliers from India (2026) — 78 Exporters, $4.2M Market | TransData Nexus | TransData Nexus

Who Exports Roxithromycin from India — 78 Suppliers Behind a $4.2M Market

India's roxithromycin export market is supplied by 78 active exporters who collectively shipped $4.2M across 427 shipments. BRAWN LABORATORIES LIMITED leads with a 30.3% market share, followed by STRIDES PHARMA SCIENCE LIMITED and MARKSANS PHARMA LIMITED. The top 5 suppliers together control 70.6% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Roxithromycin Suppliers & Exporters — 78 manufacturers, $4.2M export market, top destinations and formulations — Roxithromycin supplier data — 78 exporters · $4.2M market · 427 shipmentsTransData Nexus · Indian Customs Data

Top Roxithromycin Exporters from India — Ranked by Export Value

BRAWN LABORATORIES LIMITED is the leading roxithromycin exporter from India, holding a 30.3% share of the $4.2M market across 427 shipments from 78 exporters. The top 5 suppliers — BRAWN LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED, MARKSANS PHARMA LIMITED, TORRENT PHARMACEUTICALS LTD, GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED — collectively control 70.6% of total export value, indicating a highly concentrated market. Individual shares are: BRAWN LABORATORIES LIMITED (30.3%), STRIDES PHARMA SCIENCE LIMITED (18.2%), MARKSANS PHARMA LIMITED (14.3%), TORRENT PHARMACEUTICALS LTD (4.6%), GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED (3.2%).

Top Roxithromycin Exporters from India

Ranked by export value · 78 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Roxithromycin Exporters from India — Ranked by Export Value. 78 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Roxithromycin exporters

Certification and compliance status for top Roxithromycin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Strides Pharma Science Limited	Approved	Yes	Yes	70+	FDA inspection on March 5, 2020, resulted in No Action Indicated (NAI).
Cadila Healthcare Limited	Approved	Yes	Yes	75	FDA inspection on March 4, 2020, resulted in No Action Indicated (NAI).
Torrent Pharmaceuticals Limited	Approved	Yes	Yes	60+	WHO-GMP certification for Indrad facility as of March 14, 2006.
Micro Labs Limited	Approved	Yes	Yes	50+	WHO-GMP certification for multiple facilities.
Brawn Laboratories Limited	Not Listed	Yes	No	Not Applicable	WHO-GMP certification for manufacturing facilities.
Marksans Pharma Limited	Approved	Yes	Yes	40+	FDA approval for multiple ANDAs.
Global Pharma Healthcare Private Limited	Warning Letter with month	Yes	No	Not Applicable	FDA warning letter issued on [exact date] for [facility name].
Mercury Laboratories Limited	Not Listed	Yes	No	Not Applicable	WHO-GMP certification for manufacturing facilities.
Theon Pharmaceuticals Limited	Not Listed	Yes	No	Not Applicable	WHO-GMP certification for manufacturing facilities.
Ummedica Laboratories Private Limited	Not Listed	Yes	No	Not Applicable	WHO-GMP certification for manufacturing facilities.

TransData Nexus reviewed the regulatory standing of 10 leading Roxithromycin exporters from India. 5 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 5 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Roxithromycin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is bolstered by the Hyderabad Pharma City initiative, which aims to establish the world's largest integrated pharmaceutical hub. The city's robust infrastructure and concentration of API manufacturers make it a strategic location for sourcing active pharmaceutical ingredients like Roxithromycin.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations, accounting for 33% of India's drug manufacturing and 28% of drug exports. Vadodara hosts major pharmaceutical companies such as Alembic Pharmaceuticals, which specializes in both APIs and formulations. This region's expertise in formulations positions it as a key player in the production of finished dosage forms of Roxithromycin.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a pivotal export gateway for pharmaceuticals, leveraging Mumbai's extensive port facilities and well-established logistics network. This region's strategic location facilitates efficient distribution of pharmaceutical products, including Roxithromycin, to international markets. The presence of numerous pharmaceutical companies in this area further enhances its role in the global supply chain.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Roxithromycin exporters from India

September 2022

Acquisition

Torrent Pharmaceuticals Ltd. — Torrent Pharma acquires Curatio Healthcare for ₹2,000 crore

In September 2022, Torrent Pharmaceuticals Ltd. acquired Curatio Healthcare, a skincare product manufacturer, for ₹2,000 crore. - IMPACT: This acquisition is expected to diversify Torrent's product portfolio, potentially enhancing its market presence and export capabilities, including Roxithromycin.

Impact: This acquisition is expected to diversify Torrent's product portfolio, potentially enhancing its market presence and export capabilities, including Roxithromycin.

June 2025

Acquisition

Torrent Pharmaceuticals Ltd. — Torrent Pharma acquires controlling stake in J.B. Chemicals & Pharmaceuticals

In June 2025, Torrent Pharmaceuticals Ltd. agreed to acquire a controlling stake in J.B. Chemicals & Pharmaceuticals from KKR at an equity valuation of ₹25,689 crore, purchasing a 46.39% stake with potential to aggregate to 49.19%, followed by a mandatory open offer and a planned merger. - IMPACT: This acquisition is anticipated to strengthen Torrent's position in the pharmaceutical market, potentially increasing its export capacity for products like Roxithromycin.

Impact: This acquisition is anticipated to strengthen Torrent's position in the pharmaceutical market, potentially increasing its export capacity for products like Roxithromycin.

Common Questions — Roxithromycin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which roxithromycin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, BRAWN LABORATORIES LIMITED leads with 14 recorded shipments worth $1.3M. STRIDES PHARMA SCIENCE LIMITED (54 shipments) and MARKSANS PHARMA LIMITED (15 shipments) are also established high-volume exporters.

Q How many roxithromycin manufacturers are there in India?

India has 78 active roxithromycin exporters with a combined export market of $4.2M across 427 shipments to 30 countries. The top 5 suppliers hold 70.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Roxithromycin

Roxithromycin

Who Exports Roxithromycin from India — 78 Suppliers Behind a $4.2M Market

Top Roxithromycin Exporters from India — Ranked by Export Value

Top Roxithromycin Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Torrent Pharmaceuticals Ltd. — Torrent Pharma acquires Curatio Healthcare for ₹2,000 crore

Torrent Pharmaceuticals Ltd. — Torrent Pharma acquires controlling stake in J.B. Chemicals & Pharmaceuticals

Common Questions — Roxithromycin Suppliers from India

Q Which roxithromycin supplier from India is the most reliable for bulk orders?

Q How many roxithromycin manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Ltd. — Sun Pharma and Pharmazz Inc. enter licensing agreement for ischemic stroke drug

Q What is the typical price range for roxithromycin from India?

Analysis Methodology